Establishment of a modified intranasally ovalbumin induced animal model of allergic rhinitis.
- Author:
Yu ZHAO
1
;
C Andrew van HASSELT
;
Kong-sang WOO
;
Yeuk-oi WONG
;
Chuan-yu LIANG
;
Ping-chung LEUNG
Author Information
- Publication Type:Journal Article
- MeSH: Administration, Intranasal; Animals; Disease Models, Animal; Guinea Pigs; Nasal Lavage Fluid; Ovalbumin; administration & dosage; Rhinitis, Allergic, Perennial
- From: Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2005;40(3):176-180
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the early and late symptomatic, pathological and immunological changes in an intranasal ovalbumin-induced animal model of allergic rhinitis in guinea pigs.
METHODSGuinea pigs were intranasally sensitized with ovalbumin absorbed on aluminum hydroxide and after 5 days' interval, they were challenged with 1% ovalbumin solution once every 3 days for total 11 times. Two control groups were studied in parallel, the positive treatment control group was treated with antihistamine and the negative control group was sham-sensitized and sham-challenged. Typical symptoms of allergic rhinitis, such as sneezing, nasal scratching, nasal blockage and rhinorrhea were evaluated. Passive cutaneous anaphylaxis reaction (PCA) was performed to measure the levels of IgG1 and IgE. Eosinophils infiltration and goblet cells in nasal mucosa were observed. In addition, the level of histamine and the number of total leukocytes and eosinophils in the nasal lavage fluid were also measured.
RESULTSIn the model group, symptoms of sneezing, nasal scratching, nasal blockage and rhinorrhea were induced after ovalbumin challenge. The respiratory rate (RR), which reflected the resistance of upper airway, showed a biphasic change. In the PCA test, IgG1 and IgE levels increased after challenges. Eosinophil infiltration in nasal mucosa was more obvious in active groups in comparison to with the negative control group (P < 0.05 or < 0.01). The histamine, total leucocytes and eosinophils levels in nasal lavage fluid also showed higher in the model group (P < 0.05 or < 0.01). The antihistamine treated animals were also induced out above changes but modest compared with the model group (P < 0.05 or < 0.01). The negative control showed few of above changes with significant difference (P < 0.05 or < 0.01).
CONCLUSIONSOur results implied that the modified animal model of allergic rhinitis was capable of showing satisfactory symptomatic and pathophysiological changes in allergic rhinitis. It showed a biphasic nasal blockage with shorter establishment duration. The model also had good treatment reaction to antihistamine. The animal model we introduced may be useful in the study of allergic rhinitis.